AI assistant
IRADIMED CORP — Director's Dealing 2025
Dec 12, 2025
32324_dirs_2025-12-12_adc39d3b-674d-41ff-bf13-33b422a2718f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2025-12-11
Reporting Person: GLENN JOHN (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | Common Stock | S | 14468 | $97.26 | Disposed | 7894 | Direct |
| 2025-12-11 | Common Stock | S | 532 | $98.09 | Disposed | 7362 | Direct |
| 2025-12-11 | Common Stock | M | 1812 | — | Acquired | 9174 | Direct |
| 2025-12-11 | Common Stock | F | 714 | $97.38 | Disposed | 8460 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | Restricted Stock Units | $ | M | 1812 | Disposed | Common Stock (1812) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $97.00 to $97.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.